To understand how CBD may reduce pain, it’s important to learn the basics of the endocannabinoid system (ECS), a complex ...
A proposed CMS rule hints that some Medicare plans could cover certain legal CBD products, bringing cannabinoids a step ...
Lisa Smith’s 14-year-old daughter, Haley, had run out of options. She was having roughly two dozen seizures a day and had tried “17 or 18” different pharmaceutical regimens, different diets, and an ...
The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to antipsychotics ...
This post was co-authored by Shontae Cameron, and Robert T. Muller, Ph.D. The World Health Organization estimates that schizophrenia affects around 24 million people, or roughly 1 in 300 individuals ...
Share on Pinterest Advocates for the cannabis and hemp industries say regulation is preferable to an outright ban. Image credit: Robert Alexander/Getty Images A provision in the recent federal ...
Panelists discuss how genetics, environment, and substance use interplay to shape schizophrenia risk and guide preventive care. Panelists discuss how genetic predisposition is a major determinant in ...
If you've ever dealt with common skin woes like melasma or dryness, you've probably spent a lot of time (and money) investing in skincare products that promise to address your concerns. While it's ...
A recent Bloomberg report suggests the Centers for Medicare & Medicaid Services (CMS) may be exploring a program to cover CBD ...
A new study from researchers at King’s College London offers news evidence that cannabidiol could help regulate brain activity tied to memory and early signs of psychosis. The findings, published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback